Search
for

    Glossary Abatacept

    medication that inhibits T-cell activation to treat autoimmune diseases

    Abatacept, also known by the brand name Orencia, is a medication used to treat autoimmune conditions such as rheumatoid arthritis and certain types of juvenile idiopathic arthritis. It works by inhibiting the activation of T-cells, a type of white blood cell that plays a key role in the immune response, thereby reducing inflammation and preventing the immune system from attacking healthy tissues.

    Research 10 of 91

    1. 320 An open label clinical trial of Abatacept (CTLA4-Ig) for alopecia areata Journal of Investigative Dermatology · 2017 · 1 citations
    2. Functional Interpretation of Genome-Wide Association Study Evidence in Alopecia Areata Journal of Investigative Dermatology · 2015 · 55 citations
    3. Emerging treatments in alopecia Expert Opinion on Emerging Drugs · 2014 · 47 citations
    4. The Changing Landscape of Alopecia Areata: The Translational Landscape Advances in Therapy · 2017 · 16 citations
    5. ACTH as first line treatment for acute calcium pyrophosphate crystal arthritis in 14 hospitalized patients Joint Bone Spine · 2013 · 14 citations
    6. Novel therapies for alopecia areata: The era of rational drug development The Journal of Allergy and Clinical Immunology · 2017 · 9 citations
    7. Hair-cycle changes in two patients taking tocilizumab Joint Bone Spine · 2013 · 6 citations
    8. Current and future pharmacotherapy for alopecia areata Expert opinion on orphan drugs · 2015 · 2 citations
    9. Cytokine-targeted treatment in alopecia areata - new possibilities? Prospects in Pharmaceutical Sciences · 2023 · 1 citations
    10. Systemic Therapies for Scarring and Non-scarring Alopecia 2017 · 1 citations
    All research results →

    Learn

    — no results

    Try a deeper search in learn →

    Community

    — no results

    Try a deeper search in community →